Infants aged 2 years or younger with bronchiolitis faced an increased risk for hospitalization due to air pollution, with a meta-analysis indicating a positive association between exposure to elevated ...

No difference in the risk for eczema or bronchiolitis were noted at 1 year of age with as needed use of acetaminophen or ibuprofen.

Nirsevimab implementation in Catalonia, Spain, was associated with a 44% reduction in emergency department (ED) visits for bronchiolitis in infants younger than 6 months and a 48% reduction in ...

Bronchiolitis remains a leading cause of hospitalisation among infants and young children, prompting continuous efforts to optimise management strategies. Recent clinical approaches focus on ...

Background Bronchiolitis and its outcomes have strong socioeconomic determinants. In Liverpool, a city with high deprivation ...

A TLANTA -- Maternal respiratory syncytial virus (RSV) vaccination during pregnancy and infant RSV immunization -- either ...

According to experts, RSV is the leading cause of lower respiratory tract infections such as bronchiolitis and pneumonia that ...

The FDA approved clesrovimab (Enflonsia) to prevent lower respiratory tract disease from respiratory syncytial virus (RSV) in infants born during or entering their first RSV season, drugmaker Merck ...